Therapeutic Attack of Hypoxic Cells of Solid Tumors: Presidential Address

Cancer Research

Volumn 48, Issue 4, 1988, Pages 775-778

  Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

HYPOXIA; METABOLIC ACTIVATION; NONHUMAN; REVIEW; SOLID TUMOR;

ANIMAL; ANOXIA; HUMAN; MITOMYCIN; MITOMYCINS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023902264     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Moulder, J. E., and Rockwell, S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys., 10:695-712, 1984.
2. Moulder, J. E., and Rockwell, S. Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev., in press, 1987.
3. Dische, S. Chemical sensitizers for hypoxic cells. Radiotherap. Oncol., 3: 97–115, 1985.
4. Crabtree, H. G., and Cramer, W. The action of radium on cancer cells. II. Some factors determining the sensitivity of cancer cells to radium. Proc. Royal Soc., 113:238-250,1933.
5. Mottram, J. C. On the alteration in the sensitivity of cells towards radiation produced by cold and anaerobiosis. Br. J. Radiol., 8:32-39, 1935.
6. Hewitt, H. B., and Wilson, C. W. The effect of tissue oxygen tension on the radiosensitivity of leukaemia cells irradiated in situ in the livers of leukaemic mice. Br. J. Cancer, 13:675-684,1959.
7. Gray, L. H. Radiobiological basis of oxygen as a modifying factor in radiation therapy. Am. J. Roent., 85:803-815, 1961.
8. Bedford, J. S., and Mitchell, J. B. The effect of hypoxia on the growth and radiation response of mammalian cells in culture. Br. J. Radiol., 47: 687-696,1974.
9. Born, R., Hug, O., and Trott, K. R. The effect of prolonged hypoxia on growth and viability of Chinese hamster cells. Int. J. Radiat. Oncol. Biol. Phys., 1:687-697, 1976.
10. Koch, C. J., Kruuv, J., and Frey, H. E. The effect of hypoxia on the generation time of mammalian cells. Radiat. Res., 53:43-48,1973.
11. Koch, C. J., Kruuv, J., Frey, H. E., and Snyder, R. A. Plateau phase in growth induced by hypoxia. Int. J. Radiat. Biol., 23:67-74,1973.
12. Thomlinson, R. H., and Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9:539-549, 1955.
13. Vaupel, P. Hypoxia in neoplastic tissue. Microvasc. Res., 13:399-408,1977.
14. Vaupel, P., and Thews, G. PO2 distribution in tumor tissue of DS-carcino-sarcoma. Oncology, 30:475-484,1974.
15. Rice, G. C., Hoy, C., and Schimke, R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA, 83:5978-5982, 1986.
16. Lin, A. J., Cosby, L. A., Shansky, C. W., and Sartorelli, A. C. Potential bioreductive alkylating agents. I. Benzoquinone derivatives. J. Med. Chem., 15:1247-1252, 1972.
17. Lin, A. J., Pardini, R. S., Cosby, L. A., Lillis, B., Shansky, C. W., and Sartorelli, A. C. Potential bioreductive alkylating agents. 2. Antitumor effect and biochemical studies of naphthoquinone derivatives. J. Med. Chem., 16: 1268-1271,1973.
18. Kennedy, K. A., Teicher, B. A., Rockwell, S., and Sartorelli, A. C. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem. Pharmacol., 29:1-8,1980.
19. Sartorelli, A. C. The role of mitomycin antibiotics in the chemotherapy of solid tumors. Biochem. Pharmacol., 35:67-69,1986.
20. Lin, A. J., Cosby, L. A., and Sartorelli, A. C. Potential bioreductive alkylating agents, In: A. C. Sartorelli (ed.), Cancer Chemotherapy, pp. 71–86. Washington, DC: American Chemical Society, 1976.
21. Moore, H. W. Bioactivation as a model for drug design bioreductive alkylation. Science (Wash. DC), 197: 527-532,1977.
22. Moore, H. W., and Czerniak, R. Naturally occurring quinones as potential bioreductive alkylating agents. Med. Res. Rev., 1: 249-280,1981.
23. Powis, G. Metabolism and reactions of quinoid anticancer agents. Pharmacol. Ther., 35: 57-162,1987.
24. Kennedy, K. A., Rockwell, S., and Sartorelli, A. C. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res., 40:2356-2360,1980.
25. Teicher, B. A., Lazo, J. S., and Sartorelli, A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res., 41:73-81,1981.
26. Rockwell, S., Kennedy, K. A., and Sartorelli, A. C. Mitomycin-C as a prototype bioreductive alkylating agent: in vitro studies of metabolism and cytotoxicity. Int. J. Rad. Oncol. Biol. Phys., 8:753-755,1982.
27. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. Role of NADPH-cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44:5638-5643, 1984.
28. Kennedy, K. A., Mimnaugh, E. G., Trush, M. A., and Sinha, B. K. Effects of glutathione and ethykanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumor nuclei. Cancer Res., 45: 4071-4076,1985.
29. Fracasso, P. M., and Sartorelli, A. C. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells. Cancer Res., 46:3939-3944,1986.
30. Rauth, A. M., Mohindra, J. K., and Tannock, I. F. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res., 43: 4154–4158, 1983.
31. Iyer, V. N., and Szybalski, W. A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proc. Natl. Acad. Sci. USA, 50: 355-362,1963.
32. Matsumoto, I., and Lark, K. G. Altered DNA isolated from cells treated with mitomycin C. Exp. Cell Res., 32:192-196,1963.
33. Iyer, V. N., and Szybalski, W. Mitomycins and porfiromycin: chemical mechanism of activation and crosslinking of DNA. Science (Wash. DC), 145: 55–58, 1964.
34. Szybalski, W., and Iyer, V. N. Crosslinking of DNA by enzymatically or chemically activated mitomycins and porfiromycin, bifunctionally “alkylating” antibiotics. Fed. Proc., 23:946-957,1964.
35. Tomaz, M., Lipman, R., Chowdary, D., Pawlak, J., Verdine, G. L., and Nakanishi, K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (Wash. DC), 235:1204-1208,1987.
36. Schwartz, H. S. Pharmacology of mitomycin C. III. In vitro metabolism by rat liver. J. Pharmacol. Exp. Ther., 136:250-258, 1962.
37. Kennedy, K. A., Sligar, S. G., Polomski, L., and Sartorelli, A. C. Metabolic activation of mitomycin C by liver microsomes and nuclei. Biochem. Pharmacol., 31:2011-2016,1982.
38. Tomaz, M., and Lipman, R. Reactive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry, 20:5056-5061, 1981.
39. Komiyama, T., Oki, T., and Inui, T. Activation of mitomycin C and quinone drug metabolism by NADPH-cytochrome P-450 reductase. J. Pharm. Dyn., 2:407-410, 1979.
40. Pan, S.-S., Andrews, P. A., Glover, C. J., and Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolities catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem. 259:959-966,1984.
41. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Studies on the modulation of mitomycin C cytotoxicity by dicoumarol. Proc. Am. Assoc. Cancer Res., 28:411, 1987.
42. Rao, G. M., Lown, J. W., and Plambeck, J. A. Electrochemical studies of antitumor antibiotics. I. Cyclic voltammetric study of mitomycin B. J. Electrochem. Soc., 124:195-198,1977.
43. Rao, G. M., Lown, J. W., and Plambeck, J. A. Electrochemical studies of antitumor antibiotics. II. Polarographic and cyclic voltammetric studies of mitomycin C. J. Electrochem. Soc., 124:199-202, 1977.
44. Remers W. A. Mitomycin C and analog development. In: S. K. Crooke and S. T. Crooke (eds.), Mitomycin C, Current and New Developments, pp. 27–32. New York: Academic Press, 1979.
45. Andrews, P. A., Pan, S., and Bachur, N. R. Electrochemical reductive activation of mitomycin C. J. Am. Chem. Soc., 108:4158-4166,1986.
46. Danishefsky, S., and Giufolini, M. Leucomitomycins. J. Am. Chem. Soc., 106:6424-6425,1984.
47. Danishefsky, S. J., and Egbertson, M. On the characterization of intermediates in the mitomycin activation cascade: a practical synthesis of an aziridi-nomitosene. J. Am. Chem. Soc., 108:4648-4650,1986.
48. Lown, J. W., Begleiter, A., Johnson, D., and Morgan, A. R. Studies related to antitumor antibiotics. V. Reaction of mitomycin C with DNA examined by ethidium fluorescence assay. Can. J. Biochem., 54:110-119,1976.
49. Handa, K., and Sato, S. Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome systems as evidenced by initiation of sulfite oxidation. Gann, 66:43-47,1975.
50. Trush, M. A., Mimnaugh, E. G., Ginsburg, E., and Gram, T._E. Studies on the in vitro interaction of mitomycin C, nitrofurantoin and paraquat with pulmonary microsomes. Stimulation of reactive oxygen-dependent lipid peroxidation. Biochem. Pharmacol., 31:805-814,1982.
51. Komiyama, T., Kikuchi, T., and Sugiura, Y. Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome C reductase. Biochem. Pharmacol., 31:3651-3656,1982.
52. Bachur, N. R., Gordon, S. L., Gee, M. V., and Kon, H. NADPH-cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA, 76:954-957, 1979.
53. Kalyanaraman, B., Perez-Reyes, E., and Mason, R. P. Spin trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. Biochim. Biophys. Acta, 630:119-130,1980.
54. Bachur, N. R., Gordon, S. L., and Gee, M. V. A general mechanism for microsomal activation of quinone anticancer agents. Cancer Res., 38:1745-1750, 1978.
55. Pritsos, C. A., and Sartorelli, A. C. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res., 46:3528-3532, 1986.
56. Schwartz, H. S., Sodergren, J. E., and Philips, F. S. Mitomycin C: chemical and biological studies on alkylation. Science (Wash. DC), 142:1181-1183, 1963.
57. Komiyama, T., Oki, T., and Inui, T. Activation of mitomycin C and quinone drug metabolism by NADPH cytochrome P-450 reductase. J. Pharmacol., 2: 407-410,1979.
58. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells. Cancer Res., 47:5654-5657,1987.
59. Keyes, S. R., Heimbrook, D. C., Fracasso, P. M., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C. Adv. Enzyme Reg., 23:291-307, 1985.
60. Rockwell, S. Cytotoxicities of mitomycin C and X-rays to aerobic and hypoxic cells in vitro. Int. J. Rad. Oncol. Biol. Phys., 8:1035-1039,1982.
61. Rockwell, S., Keyes, S. R., and Sartorelli, A. C. Porfiromycin as an adjunct to radiotherapy. Abstracts of Conference on Chemical Modifiers of Cancer Treatment, October 20–24, 1985, pp. 6–12. Clearwater, FL.
62. Rockwell, S., and Kennedy, K. A. Combination therapy with radiation and mitomycin C: preliminary results with EMT6 tumor cells in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys., 5:1673-1676,1979.
63. Rockwell, S. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo. J. Natl. Cancer Inst., 71: 765-771,1983.
64. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res., 45:213-216,1985.
65. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res., 45:3642-3645,1985.
66. Spremulli, E. N., Leith, J. T., Bliven, S. F., Campbell, D. E., Dexter, D. L., Glicksman, A. S., and Calabresi, P. Response of a human colon adenocarcinoma (DLD-1) to X-irradiation and mitomycin C in vivo. Int. J. Radiat. Oncol. Biol. Phys., 9:1209-1212,1983.
67. Fu, K. K., Rayner, P. A., and Lam, K. N. Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion. Int. J. Radiat. Oncol. Biol. Phys., 10: 1473-1478,1984.
68. Von der Maase, H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumor. Radiother. Oncol., 7:47-68,1986.
69. Papac, R. J., Weissberg, J. B., Son, Y. H., Sasaki, C., Fischer, D. B., Lawrence, R., Rockwell, S., Sartorelli, A. C., and Fischer, J. J. Prospective randomized trial of radiation therapy (RT) ± mitomycin C (MC) in head and neck cancer. Proc. Am. Soc. Clin. Oncol., 6:126, 1987.